Table 4.
Mean number of days on sick leave in men remaining on initial treatment and in men with secondary treatment during the first 5 years after diagnosis
| State | Secondary treatment* | Active surveillance | Radical prostatectomy | Radiotherapy | |
| Length of stay†, days (95% CI) | Length of stay†, days (95% CI) | Length of stay†, days (95% CI) | |||
| Sick leave | All cause |
All men | 69 (63 to 75) | 95 (91 to 100) | 117 (103 to 131) |
| None | 41 (36 to 46) | 83 (79 to 87) | 111 (97 to 125) | ||
| RT | 5 (3 to 6) | 10 (8 to 11) | |||
| RP | 21 (18 to 24) | ||||
| ADT | 2 (0 to 3) | 3 (2 to 4) | 6 (2 to 10) | ||
| Prostate cancer | All men | 17 (15 to 19) | 46 (44 to 48) | 44 (38 to 50) | |
| None | 2 (1 to 2) | 40 (38 to 41) | 41 (35 to 46) | ||
| RT | 2 (1 to 2) | 5 (4 to 5) | |||
| RP | 12 (11 to 14) | ||||
| ADT | 1 (0 to 2) | 2 (1 to 2) | 3 (1 to 6) | ||
| Depression, anxiety, stress | All men | 9 (7 to 12) | 10 (8 to 12) | 12 (7 to 17) | |
| None | 6 (4 to 8) | 9 (7 to 11) | 12 (7 to 17) | ||
| RT | 1 (0 to 1) | 1 (0 to 1) | |||
| RP | 2 (1 to 3) | ||||
| ADT | 0 (0 to 1) | 0 (0 to 0) | 0 (0 to 0) | ||
| Other |
All men | 43 (38 to 48) | 40 (36 to 43) | 61 (51 to 71) | |
| None | 33 (28 to 38) | 34 (31 to 37) | 58 (49 to 67) | ||
| RT | 2 (1 to 3) | 4 (3 to 5) | |||
| RP | 7 (4 to 9) | ||||
| ADT | 1 (0 to 1) | 1 (1 to 2) | 3 (0 to 5) | ||
*RP includes men treated with RP±RT and ADT includes men treated with ADT±RT/RP.
†Number of days may not add up because of rounding.
ADT, androgen deprivation therapy; RP, radical prostatectomy; RT, radiotherapy.